drugset / Trial / NCT04431518
Pharmacokinetics of JULUCA in Hemodialysis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will compare the pharmacokinetics of the component drugs in JULUCA, and HIV combination treatment pill, in HIV-negative patients who require hemodialysis with those with normal renal function.
Timeline
- Start
- 2021-04-23
- Primary completion
- 2023-07-31
- Completion
- 2023-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dolutegravir | Other / unclassified | 50 mg | — |
| Subject | Rilpivirine | Small molecule | 25 mg | — |